ANIP
$72.67+0.15%
ANI Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.005% of ONEQRussell 3000 · 0.002% of IWVUS Stock Market · 0.002% of VTI
ANIP financial statements
The full income statement, balance sheet, and cash-flow statement for ANI Pharmaceuticals Inc. (ANIP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 19.3M2024-09 19.4M2024-12 21.1M2025-03 20.0M2025-06 20.3M2025-09 21.1M2025-12 22.5M2026-03 21.5M2026-06 21.9M+13.4% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 883M+43.8% | 614M+26.2% | 487M+53.9% | 316M+46.4% | 216M+3.7% | |
| Research & development | 51.7M+15.9% | 44.6M+30.0% | 34.3M+53.6% | 22.3M+96.3% | 11.4M-28.9% | |
| Selling, general & administrative | 318M+27.3% | 250M+54.4% | 162M+30.4% | 124M+47.2% | 84.3M+29.7% | |
| Amortization of intangibles | 82.5M+36.8% | 60.3M+15.3% | 52.3M+5.7% | 49.5M+18.4% | 41.8M+4.8% | |
| Operating income | 111M+18922.8% | 584K-98.8% | 47.0M+233.1% | -35.3M+11.3% | -39.8M-148.5% | |
| Interest expense | 32.6M-3.2% | 33.6M-5.6% | 35.6M+25.0% | 28.5M+138.7% | 11.9M+26.0% | |
| Interest & investment income | 12.5M-22.0% | 16.0M+84.3% | 8.69M+1785.9% | 461K | — | |
| Other non-operating income | 1.93M+148.0% | -4.03M-2436.5% | -159K-123.7% | 670K+115.4% | -4.34M-779.1% | |
| Gain (loss) on equity securities | 2.82M-55.2% | 6.31M | 0.00 | 0.00 | — | |
| Pre-tax income | 95.8M+531.3% | -22.2M-211.8% | 19.9M+131.7% | -62.7M-11.8% | -56.1M-115.9% | |
| Income tax | 17.5M+573.0% | -3.69M-437.6% | 1.09M+107.4% | -14.8M-9.8% | -13.5M-294.1% | |
| 78.3M+522.9% | -18.5M-198.6% | 18.8M+139.2% | -47.9M-12.4% | -42.6M-88.9% | ||
| Preferred dividends | 1.16M-28.8% | 1.63M+0.0% | 1.63M+0.0% | 1.63M+755.3% | 190K | |
| Net income to common | 77.2M+483.1% | -20.1M-217.4% | 17.2M+134.6% | -49.5M-15.7% | -42.8M-89.8% | |
| $3.32+419.2% | -$1.04-222.4% | $0.85+127.9% | -$3.05+10.3% | -$3.40-80.9% | ||
| EPS (basic) | $3.50+436.5% | -$1.04-220.9% | $0.86+128.2% | -$3.05+10.3% | -$3.40-80.9% | |
| Weighted-avg shares (basic) | 20.1M+3.8% | 19.3M+7.3% | 18.0M+10.7% | 16.3M+29.1% | 12.6M+5.3% | |
| Weighted-avg shares (diluted) | 21.2M+9.9% | 19.3M+6.2% | 18.2M+11.9% | 16.3M+29.1% | 12.6M+5.3% | |
| Dividends per share | $0.05-33.2% | $0.08-13.8% | $0.09-10.6% | $0.10+562.5% | $0.02 | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 753M+42.5% | 528M+1.7% | 520M+51.0% | 344M+7.0% | 322M+88.9% | ||
| Cash & equivalents | 286M+97.1% | 145M-34.5% | 221M+358.5% | 48.2M-51.9% | 100M+1175.4% | |
| Accounts receivable | 281M+26.8% | 222M+36.8% | 162M-2.0% | 165M+28.7% | 129M+34.2% | |
| Inventory | 143M+4.6% | 137M+23.0% | 111M+5.5% | 105M+29.0% | 81.7M+34.4% | |
| Prepaid expenses | 34.2M+90.4% | 18.0M+3.3% | 17.4M+107.5% | 8.39M+10.5% | 7.59M+29.5% | |
| 1.44B+12.1% | 1.28B+42.0% | 904M+19.0% | 760M-1.5% | 772M+67.3% | ||
| Property, plant & equipment | 62.5M+9.9% | 56.9M+27.5% | 44.6M+3.1% | 43.2M-17.9% | 52.7M+27.6% | |
| Goodwill | 62.5M+4.2% | 60.0M+112.6% | 28.2M+0.0% | 28.2M+1.2% | 27.9M+679.0% | |
| Intangible assets | 480M-11.5% | 542M+159.2% | 209M-16.9% | 252M-14.4% | 294M+56.0% | |
| Deferred tax assets | 69.1M-18.8% | 85.1M-6.2% | 90.7M+11.5% | 81.4M+19.8% | 67.9M+31.4% | |
| Other non-current assets | 13.7M+12.2% | 12.2M+1.2% | 12.1M+6.3% | 11.4M+415.2% | 2.21M+174.9% | |
| 278M+43.0% | 194M+33.7% | 145M+46.3% | 99.4M+13.6% | 87.5M+11.4% | ||
| Accounts payable | 62.6M+37.1% | 45.7M+24.5% | 36.7M+25.2% | 29.3M+27.6% | 23.0M+104.0% | |
| Accrued liabilities | 17.0M+23.6% | 13.7M+145.0% | 5.61M+3.9% | 5.39M-29.5% | 7.65M+211.5% | |
| Deferred revenue | — | — | 0.00 | 0.00-100.0% | 100K+25.0% | |
| Short-term & current debt | 17.3M+88.3% | 9.17M+979.1% | 850K+0.0% | 850K+0.0% | 850K-93.6% | |
| Current lease liability | 1.92M+6.9% | 1.80M+15.2% | 1.56M+128.2% | 684K+76.7% | 387K+200.0% | |
| Finance lease liability (current) | 104K-56.7% | 240K | — | — | — | |
| 900M+5.1% | 856M+91.6% | 447M+6.0% | 422M+2.1% | 413M+55.5% | ||
| Long-term debt | 292M-5.6% | 309M+8.5% | 285M-0.3% | 286M-0.3% | 287M+66.2% | |
| Non-current lease liability | 9.17M+108.8% | 4.39M+6.9% | 4.11M+197.7% | 1.38M+38.8% | 995K+478.5% | |
| Operating lease liability (total) | 11.1M+79.2% | 6.19M+9.2% | 5.67M+174.7% | 2.06M+49.4% | 1.38M+359.1% | |
| Finance lease liability (total) | 152K-61.6% | 396K | — | — | — | |
| Finance lease liability | 48.0K-69.2% | 156K | — | — | — | |
| Other non-current liabilities | 12.2M+110.4% | 5.78M+20.2% | 4.81M+248.2% | 1.38M-82.3% | 7.80M-46.1% | |
| 541M+33.9% | 404M-6.7% | 433M+38.0% | 314M-6.0% | 334M+70.6% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Common stock | 3.00K+50.0% | 2.00K+0.0% | 2.00K+100.0% | 1.00K+0.0% | 1.00K+0.0% | |
| Additional paid-in capital | 596M+14.7% | 520M+1.1% | 514M+27.3% | 404M+4.1% | 388M+80.9% | |
| Retained earnings | -23.1M+77.0% | -100M-25.1% | -80.1M+17.6% | -97.3M-103.7% | -47.8M-860.7% | |
| Treasury stock | 33.2M+58.0% | 21.0M+108.7% | 10.1M+97.9% | 5.09M+62.5% | 3.13M+39.6% | |
| Accumulated other comprehensive income | 1.03M-80.7% | 5.34M-39.7% | 8.86M-27.2% | 12.2M+498.3% | -3.06M+73.3% | |
| Total liabilities & equity | 1.44B+12.1% | 1.28B+42.0% | 904M+19.0% | 760M-1.5% | 772M+67.3% | |
| Common shares issued | 23.1M+7.3% | 21.5M | — | — | — | |
| Common shares outstanding | 22.5M+6.6% | 21.1M | — | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 185M+189.3% | 64.0M-46.2% | 119M+481.2% | -31.2M-1039.3% | 3.32M-78.2% | ||
| Depreciation & amortization | 91.4M+35.0% | 67.7M+13.3% | 59.8M+4.9% | 57.0M+20.6% | 47.3M+5.9% | |
| Intangible amortization | 82.5M+36.8% | 60.3M+15.3% | 52.3M+5.7% | 49.5M+18.4% | 41.8M+4.8% | |
| Share-based compensation | 37.9M+29.3% | 29.3M+42.1% | 20.7M+41.5% | 14.6M+39.2% | 10.5M-18.9% | |
| Deferred income taxes | 11.8M+151.3% | -23.0M-98.7% | -11.6M+24.0% | -15.2M+10.1% | -16.9M-30.0% | |
| Change in receivables | 58.5M+177.6% | 21.1M+727.8% | -3.36M-109.1% | 36.9M+565.3% | 5.55M-76.6% | |
| Change in inventory | 5.96M-72.0% | 21.3M+264.4% | 5.84M-75.3% | 23.6M+832.8% | -3.22M-216.9% | |
| Change in payables | 15.2M+3064.1% | 479K-93.7% | 7.55M+49.9% | 5.04M-50.4% | 10.2M+543.2% | |
| -34.3M+91.5% | -405M-2086.4% | -18.5M-17.6% | -15.7M+85.1% | -105M-54.4% | ||
| Capital expenditure | 13.8M-14.8% | 16.2M+83.1% | 8.87M-0.1% | 8.88M+247.1% | 2.56M-58.3% | |
| Free cash flow | 171M+258.7% | 47.8M-56.6% | 110M+374.7% | -40.1M-5339.1% | 765K-91.6% | |
| Acquisitions | 0.00 | 0.00 | 0.00-100.0% | 33.0K-100.0% | 84.5M | |
| Proceeds from sale of PP&E | — | — | 0.00-100.0% | 750K-71.7% | 2.65M | |
| -9.94M-103.8% | 265M+292.9% | 67.4M+1415.6% | -5.13M-102.6% | 195M+13622.9% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 80.6M | 0.00-100.0% | 69.6M | |
| Common stock repurchased | 12.2M+11.4% | 11.0M+119.8% | 4.99M+154.6% | 1.96M+120.1% | 890K-41.6% | |
| Dividends paid | 1.16M-28.8% | 1.63M+0.0% | 1.63M+0.0% | 1.63M+755.3% | 190K | |
| FX effect on cash | -233K+50.4% | -470K | 0.00 | 0.00 | — | |
| Net change in cash | 141M+284.6% | -76.2M-145.4% | 168M+422.4% | -52.1M-156.3% | 92.4M | |
| Interest paid | 26.9M+10.5% | 24.4M-22.4% | 31.4M+46.3% | 21.5M+121.3% | 9.71M+40.0% | |
| Income taxes paid | 17.7M-7.3% | 19.1M+1452.2% | 1.23M+326.4% | 288K-97.2% | 10.4M+108.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.78B+52.2% | 1.17B+10.6% | 1.05B+60.8% | 656M+0.3% | 654M+87.6% | |
| P/E | 22.7× | — | 78.8× | — | — | |
| P/S | 2.0×+5.8% | 1.9×-19.1% | 2.3×+1.3% | 2.3×-23.4% | 3.0×+81.0% | |
| P/B | 3.3×+13.6% | 2.9×+17.8% | 2.5×+16.6% | 2.1×+7.4% | 2.0×+10.0% | |
| P/FCF | 10.4×-57.6% | 24.4×+39.2% | 17.5× | — | 854.5×+2139.8% | |
| Earnings yield | 4.4% | — | 1.3% | — | — | |
| FCF yield | 9.7%+135.7% | 4.1%-28.1% | 5.7% | — | 0.12%-95.5% | |
| Dividend yield | 0.07%-53.2% | 0.14%-14.0% | 0.16%-34.8% | 0.25%+658.9% | 0.03% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ANIP’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ANIP filings on SEC EDGAR → Not investment advice.